Home › Brain Tumors › New York
Brain Tumors clinical trials in New York
35 studies for Brain Tumors are looking for participants at sites in New York.
Cities in New York
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Northwell Health Center for Advanced Medicine - Brain Tumor Center, Lake Success
- Columbia University Irving Medical Center, New York
- Montefiore Medical Center, The Bronx
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07326566A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0142, Buffalo
- Local Institution - 0170, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07492680Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05786924A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06253871A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Memorial Sloan-Kettering Cancer Center, New York
- Mayo Clinic_Rochester, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT07428616A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
- Stony Brook Cancer Center, Stony Brook
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT06764940Phase I Study of Fractionated Stereotactic Radiation Therapy
- Montefiore Medical Center, The Bronx
Recruiting
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT03726359Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
- New York University Langone's Perlmutter Cancer Institute, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT06991101Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Albany Medical Center, Albany
- SUNY Upstate Medical Center, Syracuse
- Montefiore Einstein, The Bronx
- and 1 more
RecruitingObservational study
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- Roswell Park Cancer Institute, Buffalo
RecruitingPhase 2
Ages 18 and older · Women · Updated Jul 21, 2026 · NCT04348747Chronic CED of TPT for Recurrent Malignant Glioma
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT06666712A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
- Memorial Sloan Kettering Suffolk - Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT05419076Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- State University of New York Upstate Medical University, Syracuse
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 9, 2026 · NCT03550391CONVIVO Endomicroscopy
- Northwell Health, Manhasset
RecruitingHealthy volunteers welcome
All ages · All sexes · Updated Jun 4, 2026 · NCT06087393European Prospective Investigation Into Childhood Cancer
- Columbia University Irving Medical Center, New York
RecruitingObservational study
Ages 3 to 21 · All sexes · Updated Jun 2, 2026 · NCT05375617Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- Lenox Hill Brain Tumor Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT02861898Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
- Lenox Hill Brain Tumor Center, New York
Recruiting
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05979064Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
- Lenox Hill Brain Tumor Center, New York
Recruiting
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05954858Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
- Lenox Hill Brain Tumor Center, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05271240Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- Lenox Hill Brain Tumor Center, New York
RecruitingPhase 1/2
Ages 18 to 74 · All sexes · Updated Jun 1, 2026 · NCT03213002A Study of Sotorasib in People With Brain Tumors
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering West Harrison (Limited Protocol Activities), Harrison
- and 2 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT06807619Brodalumab in the Treatment of Immune-Related Adverse Events
- Columbia University Irving Medical Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT06673329Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
- State University of New York, Downstate, Brooklyn
RecruitingObservational studyHealthy volunteers welcome
Up to age 18 · All sexes · Updated Apr 23, 2026 · NCT04322734rTMS for Postoperative Brain Tumor Patients
- Columbia University Irving Medical Center, New York
Recruiting
Ages 22 to 65 · All sexes · Updated Apr 15, 2026 · NCT07530536Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- Lenox Hill Brain Tumor Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT02800486Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT06810544Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- Weill Cornell Medicine, New York
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
- New York Presbyterian Hospital - Queens, New York
RecruitingPhase 1/2
Ages 19 to 90 · Women · Updated Mar 30, 2026 · NCT03449238Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Mar 6, 2026 · NCT05559853Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 23, 2026 · NCT06058988FUS Etoposide for DMG
- Columbia University Irving Medical Center, New York
RecruitingPhase 1
Ages 4 to 21 · All sexes · Updated Jan 28, 2026 · NCT05762419Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling
- University of Rochester, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT04965064Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
- New York-Presbyterian/Weill Cornell Medical Center, New York
RecruitingPhase 4
Ages 18 and older · Women · Updated Nov 24, 2025 · NCT06072807Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- Memorial Sloan Kettering Cancer Center, New York
Recruiting
Ages 18 and older · All sexes · Updated Oct 10, 2025 · NCT00870129S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Nyack Hospital, Nyack
- Dickstein Cancer Treatment Center, White Plains
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 8, 2025 · NCT03418961Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- Northshore University Hospital, Manhasset
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 26, 2025 · NCT01906385From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.